🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this research is to see if Loncastuximab Tesirine in combina...
Status
Recruiting
Location
Florida Cancer Specialists and Research Institute
Start Date
2022-02-11
Trial ID
NCT04998669
Treatments Being Tested
This study evaluates ADCT-402 in participants with relapsed or refractory B...
Status
Terminated
Location
UC San Diego Moores Cancer Center
Start Date
2016-03
Trial ID
NCT02669264
Treatments Being Tested
This is a prospective, phase 2, multicenter, open-label, single-arm study. ...
Status
Active Not Recruiting
Location
ASST Spedali Civili di Brescia
Start Date
2022-03-21
Trial ID
NCT05249959
Treatments Being Tested
This study evaluates ADCT-402 in participants with Relapsed or Refractory B...
Status
Completed
Location
UC San Diego Moores Cancer Center
Start Date
2016-03
Trial ID
NCT02669017
Treatments Being Tested
The Glo-BNHL trial is trying to find better medicines for children and youn...
Status
Recruiting
Location
The Children's Hospital at Westmead
Start Date
2024-05-02
Trial ID
NCT05991388
The purpose of this Phase 2 study is to evaluate the clinical efficacy and ...
Status
Completed
Location
City of Hope (City of Hope National Medical Center, City of Hope Medical Center)
Start Date
2018-08-01
Trial ID
NCT03589469
Treatments Being Tested
The main objective of the trial is to assess the efficacy and tolerability ...
Status
Terminated
Location
University of Arizona Cancer Center
Start Date
2022-06-21
Trial ID
NCT05144009
Treatments Being Tested
The overarching hypothesis for this study is that a safe and tolerable dose...
Status
Active Not Recruiting
Location
University of Texas Southwestern
Start Date
2023-01-26
Trial ID
NCT05270057
This study aims to evaluate the efficacy of single agent loncastuximab tesi...
Status
Terminated
Location
Comprehensive Cancer Centers of Nevada - Central Valley
Start Date
2021-11-04
Trial ID
NCT04699461
Treatments Being Tested
The primary objective of this study is to characterize the safety and toler...
Status
Active Not Recruiting
Location
University of California San Francisco - Fresno Center for Medical Education and Research
Start Date
2022-06-17
Trial ID
NCT04970901
Treatments Being Tested